Evidence map›Paper›PMID 34775219›Full record

ArticleBlood cells, molecules & diseases2021

Megakaryocyte-specific knockout of the Mir-99b/let7e/125a cluster lowers platelet count without altering platelet function.

Seema Bhatlekar, Shancy Jacob, Bhanu K Manne, Li Guo, Frederik Denorme, Emilia A Tugolukova, Mark J Cody, Yasuhiro Kosaka, Isidore Rigoutsos, Robert A Campbell and 3 more

Open access · greenAbstract read
In one paragraph

Article in Blood cells, molecules & diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 56% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Seema BhatlekarProgram in Molecular Medicine and Department of Internal Medicine, 15 North 2030 East, Bldg 533, University of Utah, Salt Lake City, UT 84112, United States of America.
Shancy JacobProgram in Molecular Medicine and Department of Internal Medicine, 15 North 2030 East, Bldg 533, University of Utah, Salt Lake City, UT 84112, United States of America.
Bhanu K ManneProgram in Molecular Medicine and Department of Internal Medicine, 15 North 2030 East, Bldg 533, University of Utah, Salt Lake City, UT 84112, United States of America.
Li GuoProgram in Molecular Medicine and Department of Internal Medicine, 15 North 2030 East, Bldg 533, University of Utah, Salt Lake City, UT 84112, United States of America.
Frederik DenormeProgram in Molecular Medicine and Department of Internal Medicine, 15 North 2030 East, Bldg 533, University of Utah, Salt Lake City, UT 84112, United States of America.
Emilia A TugolukovaProgram in Molecular Medicine and Department of Internal Medicine, 15 North 2030 East, Bldg 533, University of Utah, Salt Lake City, UT 84112, United States of America.
Mark J CodyProgram in Molecular Medicine and Department of Internal Medicine, 15 North 2030 East, Bldg 533, University of Utah, Salt Lake City, UT 84112, United States of America.
Yasuhiro KosakaProgram in Molecular Medicine and Department of Internal Medicine, 15 North 2030 East, Bldg 533, University of Utah, Salt Lake City, UT 84112, United States of America.
Isidore RigoutsosComputational Medicine Center, Thomas Jefferson University, 1020 Locust, Philadelphia, PA 19107, United States of America.
Robert A CampbellProgram in Molecular Medicine and Department of Internal Medicine, 15 North 2030 East, Bldg 533, University of Utah, Salt Lake City, UT 84112, United States of America.
Jesse W RowleyProgram in Molecular Medicine and Department of Internal Medicine, 15 North 2030 East, Bldg 533, University of Utah, Salt Lake City, UT 84112, United States of America.
Ryan M O'ConnellDivision of Microbiology and Immunology, Department of Pathology, Huntsman Cancer Institute, University of Utah, 2000 Cir of Hope Dr, Salt Lake City, UT 84112, United States of America.
Paul F BrayProgram in Molecular Medicine and Department of Internal Medicine, 15 North 2030 East, Bldg 533, University of Utah, Salt Lake City, UT 84112, United States of America; Division of Hematology and Hematologic Malignancies, Department of Internal Medicine, University of Utah, 2000 Cir of Hope Dr, Salt Lake City, UT 84112, United States of America. Electronic address: Paul.bray@hsc.utah.edu.
University of Utah · USThomas Jefferson University · US

Funding

Utah Center for Clinical and Translational ScienceUL1TR002538 · NCATS · UNIVERSITY OF UTAH · PI HESS, RACHEL, MAJERSIK, JENNIFER JUHL · 2018 to 2022
$26.0M
Mitochondrial fusion protein MFN2 prevents platelet death and dysfunctionR01HL144957 · NHLBI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI JESSE ROWLEY · 2019 to 2026
$3.2M
In vivo studies of megakaryocyte microRNAs regulating platelet number and integrin activationR01HL141424 · NHLBI · UNIVERSITY OF UTAH · PI BRAY, PAUL F. · 2018 to 2021
$2.5M
Interferon-Induced Transmembrane Protein 3 (IFITM3) Regulates Thrombosis During Inflammation in AgingK01AG059892 · NIA · UNIVERSITY OF UTAH · PI CAMPBELL, ROBERT A · 2019 to 2022
$400k
NCATS NIH HHS UL1 TR002538NHLBI NIH HHS R01 HL141424NHLBI NIH HHS R01 HL144957NIA NIH HHS K01 AG059892
6 · The paper itself

Abstract

The purpose of this research was to assess the effects of a microRNA (miRNA) cluster on platelet production. Human chromosome 19q13.41 harbors an evolutionarily conserved cluster of three miRNA genes (MIR99B, MIRLET7E, MIR125A) within 727 base-pairs. We now report that levels of miR-99b-5p, miR-let7e-5p and miR-125a-5p are strongly correlated in human platelets, and all are positively associated with platelet count, but not white blood count or hemoglobin level. Although the cluster regulates hematopoietic stem cell proliferation, the function of this genomic locus in megakaryocyte (MK) differentiation and platelet production is unknown. Furthermore, studies of individual miRNAs do not represent broader effects in the context of a cluster. To address this possibility, MK/platelet lineage-specific Mir-99b/let7e/125a knockout mice were generated. Compared to wild type littermates, cluster knockout mice had significantly lower platelet counts and reduced MK proplatelet formation, but no differences in MK numbers, ploidy, maturation or ultra-structural morphology, and no differences in platelet function. Compared to wild type littermates, knockout mice showed similar survival after pulmonary embolism. The major conclusions are that the effect of the Mir-99b/let7e/125a cluster is confined to a late stage of thrombopoiesis, and this effect on platelet number is uncoupled from platelet function.

Indexed as

AnimalsBlood PlateletsGene DeletionHumansMegakaryocytesMiceMice, Inbred C57BLMice, KnockoutMicroRNAsMultigene FamilyPlatelet CountPlatelet Function TestsThrombocytopeniaThrombopoiesisMicroRNAsMirn125 microRNA, mouseMirn99 microRNA, mousemirnlet7e microRNA, mouseConditional knockout miceMegakaryocyteMir-99b/let7e/125a clusterPlatelets

Identifiers

PMID34775219
PMCPMC8682963
OpenAlexW3209734508

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.